GlassScriptPhysician profile
Christopher A Worgul
NPI 1780034678
$7,681.66
in general payments reported to CMS, 2019-2025
11 companies · $2,173 in 2025
The $2,173 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2021: $54.21 · 2022: $239 · 2023: $123 · 2024: $4,991 · 2025: $2,173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,152 · Travel and Lodging: $3,067 · Education: $67.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,152.48 |
| Travel and Lodging | $3,066.59 |
| Education | $67.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,037.00 | 2021-2025 | Mako, Triathlon, T2 Alpha |
| Zimmer Biomet Holdings, INC. | $1,101.97 | 2024-2025 | Avenir, Oxford, Oxford Partial Knee |
| Smith+Nephew, INC. | $611.25 | 2024 | Evos, Maverick, Trigen Intertan |
| Medical Device Business Services, INC. | $368.80 | 2021-2025 | Velys |
| Orthalign INC | $172.15 | 2022 | |
| Innovation Technologies INC | $169.17 | 2024 | Irrisept |
| Olympus America INC. | $87.13 | 2019 | |
| Medacta USA, INC. | $59.00 | 2024 | |
| Ethicon US, LLC | $39.47 | 2025 | Dermabond Prineo, Stratafix |
| Vertex Pharmaceuticals Incorporated | $20.60 | 2025 | |
| Bard Peripheral Vascular, INC. | $15.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Worgul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.